MORGAN WILKERSON: Open Payments
NPI 1992229371 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 19 payments from 14 companies in 2025. Trend: 2023 $528 · 2024 $437 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 3 | $81 |
| Organon LLC | 2 | $60 |
| SHIELD THERAPEUTICS INC | 2 | $50 |
| Exeltis, USA Inc. | 2 | $44 |
| ABBVIE INC. | 1 | $31 |
| PFIZER INC. | 1 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
Products named: ZURZUVAE, NEXPLANON, ACCRUFER, SLYND, LILETTA, ABRYSVO, Qelbree, EVENITY.
Industry payments across MD — which companies pay providers there.
